Picture of Evolent Health logo

EVH — Evolent Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Evolent Health Inc reports results for the quarter ended in September 30 - Earnings Summary

* Evolent Health Inc  EVH.N  reported quarterly adjusted
earnings
of 4 cents​​ per share for the quarter ended September 30, lower
than the same quarter last year, when the company reported EPS
of 30 cents.  The mean expectation of fifteen analysts for the
quarter was for earnings of 34 cents per share. Wall Street
expected results to range from 22 cents to 41 cents per share.
    * Revenue rose 21.6% to $621.40 million from a year ago;
analysts
expected $627.15 million. 
    * Evolent Health Inc's reported EPS for the quarter was a
loss
of 27 cents​.
    * The company reported a quarterly loss of $31.23 million.
    * Evolent Health Inc shares had fallen by 12.4% this
quarter and
lost 25.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Evolent Health
Inc is $38.50 
This summary was machine generated from LSEG data November 8 at
04:52 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.34           0.04           Missed
 Jun. 30 2024      0.25           0.30           Beat
 Mar. 31 2024                     0.34           
 Dec. 31 2023      0.15           0.23           Beat

Recent news on Evolent Health

See all news